The passing of FIP CEO Mr A.J.M. (Ton) Hoek

Reference: http://fip.a1.mailplus.nl/genericservice/code/servlet/React?encId=jXCpi6ez8YmwFHD&actId=105724&command=openhtml

Click here to view the online version
alt alt alt
International Pharmaceutical Federation
alt
July 2012
alt
alt
alt alt
alt

 Mr A.J.M. (Ton) Hoek
1955-2012

It is with the deepest regret and sadness that we must announce the passing of our leader, colleague and friend, FIP CEO Mr A.J.M. (Ton) Hoek. Mr Hoek passed away this Saturday July 28th after a short but courageous battle with cancer.
 
Mr Hoek took the helm of FIP in 1999 and since that time brought the Federation to entirely new levels of development and accomplishments, especially in solidifying key global partnerships like that with the World Health Organization (WHO) and in incorporating FIP as a Founding Partner in the World Health Professions Alliance (WHPA). His efforts in extending FIP’s outreach and impact not only elevated FIP to the position of an influential global stakeholder in medicines and health, but raised the image of the pharmacist as a healthcare provider around the world. Mr Ton Hoek was named an Officer in Order of Orange-Nassau, a royal declaration bestowed by the Queen of the Netherlands.
 
The culmination of Mr Hoek’s vision comprises the events that will take place at the upcoming FIP Centennial Congress, including a Ministers Summit on The Responsible Use of Medicines, organised by the Dutch Ministry of Health. This dream had been in the making for many years and will be realised to its fullest potential thanks to his efforts.

alt
Contacting fip  
alt PO Box 84200
2508 AE The Hague
The Netherlands

Tel.: +31-70-3021970
Fax: +31-70-3021999
Email: fip@fip.org

alt
alt alt
alt To change your contact information or to unsubscribe, please use this link.
Here you can also change your preferences.
 

Western Pacific Pharmacy and Pharmacology Schools on Top of World

Western Pacific Pharmacy and Pharmacology Schools on Top of World

 

The Western Pacific regional schools of pharmacy are among world leaders in the QS World Ranking by Disciplines for 2012.

 

Ten of the Western Pacific schools of pharmacy and pharmacology rank in the top 50 globally.

 

Addressing a meeting of pharmacists and government officials in Seoul, Korea, Western Pacific Pharmaceutical Forum President John Ware, in announcing these results, said what a great achievement for our region and congratulated Korea as the Seoul National University was in the group.

 

The QS ranking lists the best schools in the world at which to study pharmacy and pharmacology. Six faculties in the Western Pacific region were in the top 25.   The National University of Singapore was listed at number 3 and the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University, Australia was ranked at number 6.

 

In the first six ranked universities, were Harvard, US; University of Cambridge, UK; Oxford University, UK and the Karolinska Institute in Sweden.

 

These were followed by the University of Tokyo at number 8, University of Melbourne at 9, University of Queensland at 13 and the University of Sydney at 22.

 

The full list of the schools in the Western Pacific region is listed below.

 

Ranking

University

3

National University of Singapore (Singapore)

6

Monash University (Australia)

8

University of Tokyo (Japan)

13

The University of Queensland (Australia)

22

The University of Sydney (Australia)

34

University of Hong Kong (Hong Kong)

35

The University of New South Wales (Australia)

41

The University of Auckland (New Zealand)

43

National Taiwan University (Taiwan)

50

Seoul National University (South Korea)

 

 

Associate Professor Wai Keung Chui, Vice-President of the Western Pacific Pharmaceutical Forum and also an Associate Professor of the National University of Singapore, on being congratulated, said it was a great achievement, not only for the National University of Singapore, but for the whole region.

 

Professor Bill Charman, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Australia, said the following.

‘Results such as these recognise the investment the faculty has made in developing innovative and challenging undergraduate and postgraduate courses.’

 

The key message from this ranking is that our staff, programs, activities and outcomes are respected and valued, by the leaders in our discipline worldwide.’

‘We do not seek to ‘chase’ rankings in what we do, instead we continue to focus on excellence and quality in our education, research and professional activities. And we seek to attract and retain the most talented staff and students.’

‘This ranking clearly recognises what Monash is achieving in the discipline of pharmacy and pharmacology. The ranking draw heavily on our academic reputation as judged by our peers and is testimony to the fact that our students are receiving world-class education.’

 

On behalf of the Western Pacific Pharmaceutical Forum, the President, John Ware, extends congratulations on these outstanding rankings.

He said it was incredible that out of the 50 top schools of pharmacy and pharmacology globally, 20% of those schools were in the Western Pacific region. It shows that our region is not just a world economic leader, but a leader in education and pharmaceutical research.

News in 1 Shot (July 2012)

Summary of WPPF News Update

Topic News

*

2012 2nd WPPF Executive Meeting – Country Reports Summary and Photos

1.

WHPA Releases Report on Forum for “Collaborative Practice”

2.

Mr Ton Hoek, FIP CEO named Officer in the Order of the Orange-Nassau

3.

Japan Pharmaceutical Association: Board members June 2012

4.

Food and Drug Administration plans to promote the relevant management and standard for pharmacists to sell medical devices through virtual channels

 

 

News

1.

[NPS]: News Update July

2.

[WHO]: News Update July

3.

FIP News 4 July 2012

4.

Press invitation FIP Centennial Congress

5.

The drug price reduction scheme took effect

6.

[Publication – Forefront]: Issue 24~27

7.

MPA website to foster clarity on the PBS

8.

PAC12 Early Bird registrations extended

9.

Professional service design and delivery come to life in September 2012

10.

PSA releases draft mental health care framework

11.

Overview in Critical Care

12.

KYPG PLUS DAY

13.

The 63th National License Examination for Pharmacists

14.

Major Change in Taiwan’s “Regulations of Inspection and Sealing for Biological Drugs”

15.

Many misread adverts: survey

 

 

International

1.

[WHO]: News Update July

 

 

Publication

1.

[NPS]: News Update July

 

FIP News 4 July 2012

 

 

Upcoming Event

1.

01.07.2012 – 31.08.2012
PSA-National Intern Training Program course

2.

28.07.2012
World Hepatitis Day

3.

19.08.2012
World Humanitarian Day

4.

27.08.2012 – 04.10.2012
Annual meetings of WHO Regional Committees

5.

29.08.2012
Philippine Pharmacists Association, Inc 92nd Anniversary in PPhA Building

 

 

Public Health

1.

N/A

 

 

PharmacyEducation E-learning

1.

NPS Prescribing Practice Review 59: Investigating headache

2.

Latest Clinical Audits July 2012 

 

 

2012 2nd WPPF Executive Meeting in Seoul, Korea – Country Reports Summary and Photos (2)

Reference:  Country Reports provided by Executive Secretary Mrs. Nariel Ware

                  Photos provided by Korea Pharamceutical Association

img_0873

Country report Vietnam.doc
Country report Japan.doc
Country report Philippines.doc
Country report Singapore.doc
Country report Taiwan.doc
Country report Korea.doc

img_0879

 

img_0882

 

img_4106

 

img_4266

[NPS]: News Update July

Reference:   

http://www.nps.org.au/health_professionals/publications/prescribing_practice_review

http://www.prodocom.com.au/html/actions/viewonline.php?ID=286926&cc=&loc=783a5c372d31315c74656d705c6175636f6d616d70636f677368756d5c68746d6c656d61696c5c3238363932365c3836353731325c6174746163685c&email=pharmtw@gmail.com

Title Date
NPS Prescribing Practice Review 59: Investigating headache July 2012

——————————————————

 
null
    MANAGEMENT OF SPECIFIC RESPIRATORY TRACT INFECTIONS  
    •  Audit is ongoing                                                                              ONLINE
 
 
 
 
 
null
   HEADACHES: SAFE DIAGNOSIS, EFFECTIVE MANAGEMENT  
   •  Submit forms by 7 September 2012                                PAPER BASED
 
 
 
 
 
 
null
   DEPRESSION: CHALLENGES IN PRIMARY CARE  
   •  Submit forms by 19 October 2012                                   PAPER BASED
 
 
 
 
 
 
null
   REVIEW OF PROTON PUMP INHIBITOR (PPI) PRESCRIBING  
   •  Audit is ongoing                                                                     ELECTRONIC
 
 
 
 

For more information visit

COMING SOON

 
1

TYPE 2 DIABETES ONLINE
Available December 2012

 
 

_________________________________________________________________________

INFORMATION FROM NPS – AT NO COST TO YOU!
   
Order NPS has many free resources for use by health professionals. To view and order from our
extensive range of medicines information resources, visit the NPS online catalogue.
   
RSS Feed Would you like us to tell you when new information for health professionals is
released?  If so, you can subscribe to an NPS RSS feed or e-alert.
   
To view our privacy policy click here.
   
To unsubscribe or update your details click here.

_________________________________________________________________________

This email has been sent to you from NPS: Better choices, Better health. For a MedicineWise Australia.
Independent. Not-for-profit. Evidence based. Funded by the Australian Government Department of Health
and Ageing. For more information about NPS please visit www.nps.org.au. Head Office: 7/418A Elizabeth
Street, Surry Hills NSW 2010 ©2012 National Prescribing Service Limited ABN: 61 082 034 393

_________________________________________________________________________

WHPA Releases Report on Forum for “Collaborative Practice”

Reference:  http://www.fip.org/www/index.php?page=latest_news&news=newsitem&newsitem=127

Some 35 participants registered for the WHPA forum on collaborative practice, held in Geneva on 20 May 2012. FDI President Dr Orlando Monteiro da Silva chaired the morning session, briefly addressing the session on the pressing need for close collaboration among the difference health professions.

Click here to read the full report 

[WHO]: News Update July

Reference:  http://www.who.int/en/

                      http://www.who.int/mediacentre/news/en/

                      http://www.who.int/medicines/publications/newsletter/en/

                      http://www.who.int/medicines/publications/druginformation/en/index.html

XIX International AIDS Conference 2012 opens: from treatment to ending transmission of HIV

22 July 2012 — The XIX International AIDS Conference (AIDS 2012) opened on Sunday, 22 July in Washington, DC. During the conference, WHO is presenting a discussion paper on the strategic use of antiretroviral drugs (ARVs) and a report on HIV drug resistance. WHO has released new recommendations on the use of ARVs for pre-exposure prophylaxis (PrEP), guidance on HIV services for sex workers, and guidance on the prevention of HIV and hepatitis among people who inject drugs.  

Read more about the AIDS Conference 2012

Reducing hepatitis infections in people who inject drugs

21 July 2012 — WHO has identified four key actions countries can take to prevent viral hepatitis B and C among people who inject drugs. Of the estimated 16 million people who inject drugs worldwide, it is estimated that 10 million are infected with hepatitis C. An additional 1.2 million are infected with hepatitis B. New guidelines issued by WHO provide the first step to comprehensive guidance on viral hepatitis surveillance, prevention and treatment.

Using HIV medications to protect people at high risk of infection

20 July 2012 — WHO issues its first guidance to countries that are considering offering antiretrovirals (ARVs), to protect people who do not have the virus but who are at high risk of HIV infection. Clinical trials have shown that a daily dose of oral antiretroviral medication, known as pre-exposure prophylaxis (PrEP), taken by HIV-negative people to reduce the risk of infection, is both safe for people to use and effective in preventing HIV.

Strategic use of HIV medicines could help end transmission of virus

18 July 2012 — More strategic use of antiretroviral HIV medications can significantly reduce the transmission of the virus according to WHO proposals that will be presented at the XIX International AIDS Conference in Washington, DC on Sunday. “We now have evidence that the same medicines we use to save lives and keep people healthy can also stop people from transmitting the virus and reduce the chance they will pass it to another person,” says Dr Margaret Chan, Director-General, WHO.

——————————————————————————-

News releases

  • ‘Strategic use’ of HIV medicines could help end transmission of virus 
    18 July 2012 — More strategic use of antiretroviral HIV medications can significantly reduce the transmission of the virus according to WHO proposals that will be presented at the XIX International AIDS Conference in Washington, DC on Sunday.
  • UN food safety body sets limits on veterinary growth promoting drug 
    6 July 2012 — The UN food standards body has agreed on a set of residue limits for the veterinary drug ractopamine in animal tissues. The decision was made after a rigorous process of scientific assessment to ascertain that the proposed levels of residues of the growth promoting drug have no impact on human health.

Statements

Notes for the media

———————————————————————————————————-

WHO Pharmaceuticals Newsletter

No. 3, 2012

Share

Authors:
Quality Assurance and Safety

WHO Pharmaceuticals Newsletter

Publication details

EditorsShanthi Pal, Daisuke Koga
Number of pages25
Publication dateJune 2012
LanguagesEnglish

Downloads

The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicines and legal actions taken by regulatory authorities across the world. It also provides signals from the Uppsala Monitoring Centre’s SIGNAL document.

The feature articles in this issue give you a brief summary of a course offered by the WHO Collaborating Centre for Drug Satistics Methodology; and a pilot project being launched by the Uganda National Drug Authority, to collect pharmacovigilance data in their HIV treatment programmes.

——————————————————————————————————————————

WHO Drug Information

Volume 26, N° 2, 2012

Share

Authors:
QSM

WHO Drug Information

Publication details

Number of pages139
Publication date30 June 2012
LanguagesEnglish

Downloads

The second issue for 2012 features an article on the WHO Prequalification of Medicines Programme which, since 2009, has been hosting and coordinating a novel quality risk assessment mechanism on behalf of the Global Fund to Fight AIDS, Tuberculosis and Malaria. The Expert Review Panel assesses quality risks of pharmaceutical products which do not yet meet stringent quality requirements. Based on standardized, transparent criteria, it gives advice on whether a product is acceptable for procurement for the next 12 months. The process has promoted progression of many medicines to prequalification: of 115 eligible products assessed by the ERP in 2009 and 2010, 44 went on to become prequalified or approved by a stringent regulatory authority. Agencies are using the mechanism jointly and this has resulted in harmonized quality assurance policies, unified quality standards and efficiency gains.

The section on Safety and Efficacy highlights information on signals and reports of adverse drug reactions, with other news from around the world, including labelling changes. This is complemented by the section on Regulatory Action and News which provides the most recent developments from regulatory authorities, and particularly those having an impact on decision-making and risk assessment.

The final and temporary lists of ATC/DDD Classifications adopted by the WHO International Working Group for Drug Statistics Methodology are also presented.

The final section, Recent Publications, Information and Events, provides brief summaries of several recently-published documents and online resources.

The journal concludes with the 107th Proposed List of International Nonproprietary Names (INN).

FIP News 4 July 2012

Reference:  http://fip.a1.mailplus.nl/genericservice/code/servlet/React?encId=jXCpi6ez8YmwFHD&actId=104263&command=openhtml

Click here to view the online version
Newsletter for Member Organisations
4 July 2012
News from FIP

Update Regarding FIP Centennial Top 100 Pharmacists

Dear FIP Member Organisations,

It is our regrettable task to inform you that the Top 100 Pharmacists project has been put on hold and the Top 100 Pharmacists list will not be released at the FIP Centennial Congress.

This has been a difficult decision for FIP, one that is reflective of internal challenges that FIP is currently facing, and which by no means is a result of the quality of the nominations received, or of those who nominated them.  Through this initiative we have come to be reminded of the wonderful work that has been – and continues to be – done by pharmacists globally, and we commend each and every nominee for their on-going efforts in upholding and advancing the profession of pharmacy throughout the world.

Again, on behalf of FIP and our officers, many apologies for this unfortunate turn of events. We will be in touch in the future should we recommence the nomination process and will keep all nominated individuals on file for future consideration. We greatly value the work invested to date in the nomination process and are dedicated to acknowledging all involved.

Should you have any questions, please do not hesitate to contact FIP Headquarters at fip@fip.org.

Thank you greatly for your understanding.

WHPA Releases Report on Forum for “Collaborative Practice”
Some 35 participants registered for the WHPA forum on collaborative practice, held in Geneva on 20 May 2012. FDI President Dr Orlando Monteiro da Silva chaired the morning session, briefly addressing the session on the pressing need for close collaboration among the difference health professions.

Click here to read the full report

FIP Collaborates with the WGO for World Digestive Health Day
FIP has recently collaborated with the World Gastroenterology Organisation and contributed an article on the pharmacist’s role in GI health for a published supplement for World Digestive Health Day.

Click here to read the full article.

News from FIP Member Organisations
Turkish Pharmacists Association (TPA) successful in updating laws
After years of working towards positive changes in the laws governing  the pharmacy profession in Turkey, the Turkish Pharmacists’ Association is pleased to announce the following developments, with new laws approved unanimously on 17.05.2012 and published at the official newspaper on 30.05.2012 .

The major statements are as follows:

1. Professional activities/operations/rights of pharmacists redefined enlarging professional  fields where pharmacists are the only people with responsibility.

2. Ownership criteria is strenghtened saying ONLY a pharmacist can open and own a pharmacy. One pharmacist one pharmacy and closing the pathway to chain pharmacies. Unethical/illegal  ownership arrangements,if detected, is a reason for 5 years penalty for the pharmacist. If they are colleagues everyone of them will be punished.

3. Demographic restriction for every 3500 inhabitants per pharmacy. All present pharmacists either working or not and present students in faculties have right to open a pharmacy without any restriction at any place. Beginning this year new pharmacy students have to adapt themselves to restrictions.

4. Products to be sold in pharmacies are redefined. Pharmaceuticals, licenced traditional herbal products, homeopathic products, special diet products and enteral nutritional products can ONLY be dispensed/sold in pharmacies.

Licenced food supplements, veterinarian products (together with veterinarians), cosmetics, baby foods, nutritional products for metabolism disorders, medical devices  can be sold in pharmacies.

This statement also closes the way for pharmaceuticals to be sold outside of pharmacies again.

5. Presidency members of TPA Executive Committee must assign a responsible pharmacist for their community pharmacies and their salary will be paid by TPA.

Should you wish more information on the background of these changes please contact fip@fip.org to be connected to the TPA.

News From the FIP Centennial
Limited rooms still available at the official Centennial hotels!
We are now just a few short months away until the biggest event in FIP History, the FIP Centennial Congress in Amsterdam, 3-8 October 2012! If you haven’t done so already, visit the FIP Congress website to book your Congress Hotels. There is still limited space available at the two official Centennial hotels – the stunning Okura, featuring 5-star service and Michelin dining, complete with rooftop views of the entire city; and the Apollo, the perfect place to mix both business and pleasure. Both are conveniently located within walking distance to the FIP Centennial venue (the RAI Convention Centre) with easy access to the Amsterdam city centre.  Click here to ensure your comfortable and convenient stay in Amsterdam!

NEW in 2012 – the FIP Pharmacy Technicians and Support Workforce Symposium
New to the FIP Congress this year is a special Pharmacy Technicians and Support Workforce Symposium. The inaugural Symposium will provide pharmacy technicians and members of the pharmacy support workforce valuable tools to further develop skills in these areas and have a greater positive effect on pharmacy functioning and patient care. This will be examined through three sessions:

  • Role of the Pharmacy Technician Worldwide
  • Education for the Pharmacy Support Staff
  • Patient Safety – how can technicians best support patient safety initiatives in the pharmacy?


Click here for more information and to register!

FIP Congratulates
FIP would like to congratulate Dra. Q.F. Virginia Olmos on her election as the President of the Association of Chemistry and Pharmacy of Uruguay and Dr Isabelle Adenot on her re-election as President of the Conseil national de l’Ordre des pharmaciens, France.
Upcoming Events
   
To register for the congress, please clickHERE
For more information:
Email: congress@fip.org
FIP Centennial Website
Tel.: +31-70-3021970
Fax: +31-70-3021999
 Like us!



  Reminder – visit the FIP website for all the latest news and benefits for Member Organisations!  
FIP endeavors to constantly update and expand our website – check back frequently news and updates from FIP and around the world. 

  Joint WHO-FIP Statement on GPP Guidelines – French and Spanish available  

The French and Spanish translations of the Joint WHO-FIP Statement on Good Pharmacy Practice Guidelines are now available on the FIP website here 


  Did you know  
FIP is the global federation of national associations representing 2 million pharmacists and pharmaceutical scientists around the world.

  Contacting fip  
PO Box 84200
2508 AE The Hague
The Netherlands

Tel.: +31-70-3021970
Fax: +31-70-3021999
Email: fip@fip.org
  Like us!

To change your contact information or to unsubscribe, please use thislink.
Here you can also change your preferences.
 

Mr Ton Hoek, FIP CEO named Officer in the Order of the Orange-Nassau

Reference:  http://fip.a1.mailplus.nl/genericservice/code/servlet/React?encId=2iBffZr5irQxhAt&actId=105090&command=openhtml

Click here to view the online version
International Pharmaceutical Federation
18 July 2012
Mr Ton Hoek, FIP CEO named Officer in the Order of the Orange-Nassau

FIP is extremely proud to announce that the Federation’s CEO and General Secretary, Mr Ton Hoek, was named an Officer in the Order of the Orange-Nassau, a royal declaration bestowed by the Queen of the Netherlands and handed over in person by the Mayor Fons Hertog of Huizen.

All who have had the privilege of working with Mr Hoek within the vast global, healthcare circles he impacts are not surprised at such an honour. He has dedicated his career not only to the world-wide promotion of pharmaceutical care, but to the global advancement of pharmacy, the pharmaceutical sciences and pharmacy education through visionary leadership and influence, all to much success.

Mr Hoek’s accomplishments have been self-evident throughout his 13 years at the helm of FIP, but also in his positive impact on the Federation’s partners throughout the world. This global outreach was recognised at the ceremony as well, with an honorary resolution from the American Pharmacists Association (APhA) citing his active dedication to pharmacy and a joint congratulatory letter from the APhA, the American Academy of Colleges of Pharmacy (AACP), the American Academy of Pharmaceutical Sciences (AAPS) and the American Society of Health-Systems Pharmacists (ASHP).

The extended FIP network and family is exceptionally proud of Mr Hoek for this award and the accomplishments that have led to it. More so, we are grateful to him for extending his vision and leadership in a way that has allowed us all to be a part of his success.

Upcoming Events
   
To register for the congress, please clickHERE
For more information:
Email: congress@fip.org
FIP Centennial Website
Tel.: +31-70-3021970
Fax: +31-70-3021999
 Like us!



  Contacting fip  
PO Box 84200
2508 AE The Hague
The Netherlands

Tel.: +31-70-3021970
Fax: +31-70-3021999
Email: fip@fip.org
  Like us!

To change your contact information or to unsubscribe, please use thislink.
Here you can also change your preferences.
 

Press invitation FIP Centennial Congress

Reference:  http://fip.a1.mailplus.nl/genericservice/code/servlet/React?encId=2iBffZr5irQxhAt&actId=105144&command=openhtml

View this email online.
Add fip@fip.org to your your addressbook and stay up to date.

Responsible use of medicine can lead to a dramatic decrease of unnecessary hospital admissions

The FIP urges both the public and policy makers to become aware that one of the main challenges in health care worldwide is irresponsible use of medicine. It has a direct influence on both effectiveness and cost-efficiency of health care. For instance: each year millions of people are hospitalized due to potentially avoidable, medicine-related, factors. It is estimated that in the US alone hospital admissions due to poor medication adherence cost $1 billion US per year.

Non-adherence is one of the most important reasons for these hospitalizations. An estimated 50% of chronic patients don’t take all the medicines prescribed to them. In low- and middle-income countries rates are even lower. With the number of people suffering from a chronic disease increasing from 43% of the current burden of disease to 60% of the disease burden and 73% of all deaths by 2020, we must find a solution now.

Therefore FIP is organizing a Centennial Congress, from the 3rd to 8th October, with the focus of finding solutions to these challenges and creating a global environment of more responsible use of medicines. Pharmacists are the most accessible health care professionals: they are close to the public and freely available. This, combined with their unique knowledge on medicines, make them the key party to address the problem of irresponsible medicines use and find solutions for it.

We would like to invite you to attend this Congress.

When: 3 – 8 October 2012
Where: Amsterdam RAI Congress Center, The Netherlands

Ministers Summit (3 October)
A complimentary element to the Centennial Congress is an international Ministers Summit hosted by the Dutch Ministry of Health. Considering the vast, global impact of this subject, the Dutch Minister of Health, Edith Schippers, commissioned the IMS and World Health Organization (WHO) to compile the latest world-wide data on the prevalence and effect of irresponsible medicines use.  Their findings will be published in reports, to be released in September and discussed during the Ministerial Summit.

Please apply for the FIP Centennial Congress by sending an email to press@fip.org. For questions please visitwww.fip.org/centennial or contact Sophie van den Oord, (+31) 20‑5437600, svdoord@porternovelli.nl or Corine Solleveld, (+31) 20‑5437600, csolleveld@porternovelli.nl.

With kind regards,

Myriah Lesko
FIP Manager of Media and Publications

The International Pharmaceutical Federation – FIP
The International Pharmaceutical Federation (FIP) is a representative of over two million of the world’s pharmacists and pharmaceutical scientists through 127 Member Organisations. They are an invaluable global leader and partner in medicines expertise and healthcare advancement, developing strategies and policies implemented by Members the world over.

Upcoming Events  

To register for the congress, please clickHERE
For more information:
Email: congress@fip.org
FIP Centennial Website
Tel.: +31-70-3021970
Fax: +31-70-3021999
 Like us!


Contacting FIP
Email: fip@fip.org
Web: www.fip.org
Tel.: +31-70-3021970
Fax: +31-70-3021999

PO Box 84200
2508 AE The Hague
The Netherlands

  Like us!

Update your contact information
Please click here to view or change your contact information and your preferences.
You can change your contact information or unsubscribe from this mailing. You can also change your preferences. Forward this email